APPLICATION
ANDA078039
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-14
LATEST ACTION
2024-11-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
MELOXICAMDiscontinued
MELOXICAM 7.5MG · TABLET · ORAL
MELOXICAMDiscontinued
MELOXICAM 15MG · TABLET · ORAL
Approval history
2024-11-26Labeling · Supplement 4 · standardAP
2014-11-28Manufacturing (CMC) · Supplement 2AP
2006-12-14OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.